?dT Cell Cancer Immunotherapy : Evidence-Based Perspectives for Clinical Translation Hardback
Edited by Marta (University College London, Experimental Paediatric Oncology Research Group and Alloge Barisa
Part of the Breaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy series
?d T Cell Cancer Immunotherapy: Evidence-Based Perspectives for Clinical Translation discusses the current pre-clinical and clinical ?d T cell landscape.
The book not only focuses on the promises of whatâ€™s to come, but also on the challenges faced by the field.
Particular attention is given to summarizing recent advances on what is known about relevant areas of ?d T cell biology on summarizing the â€˜big pictureâ€™ clinical situation, an up-to-date systematic clinical trial review covering autologous, allogeneic, engineered and non-engineered therapies, and perspectives on the types of cutting-edge gene-engineering that may be required to enhance the effect-size and durability of therapeutic efficacy.
Content provides updated and comprehensive insights into the current state of ?d T cell immunotherapy, including discussions on the promise as well as challenges of the field that is of interest to existing translational ?d T cell specialists, the proliferating range of academic scientists and commercial scientists entering the field, as well as clinicians who may encounter ?d T cell immunotherapy in the clinic or are wishing to familiarize themselves with non-canonical lymphocyte immunotherapy.